NEW ORLEANS, Sept. 29, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 6, 2017 to file lead plaintiff applications in a securities class action lawsuit against MAXIMUS, Inc. (NYSE:MMS), if they purchased the Company’s shares between October 30, 2014 and February 3, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of Virginia.
Get Help
MAXIMUS investors should visit us at https://www.claimsfiler.com/cases/view-maximus-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
MAXIMUS and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) in obtaining a significant contract (“the HAAS contract”), the Company established unachievable goals for personnel recruitment and performance; (ii) the Company had difficulty meeting the goals in its performance of the contract; (iii) its failure to meet the performance goals would cause MAXIMUS to forfeit the incentive fees under the contract; and (iv) as a result of the foregoing, MAXIMUS’ financial statements were materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



